Evidence map›Paper›PMID 39061811›Full record

ArticleBioengineering (Basel, Switzerland)2024

ViT-PSO-SVM: Cervical Cancer Predication Based on Integrating Vision Transformer with Particle Swarm Optimization and Support Vector Machine.

Abdulaziz AlMohimeed, Mohamed Shehata, Nora El-Rashidy, Sherif Mostafa, Amira Samy Talaat, Hager Saleh

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Advances in AI Technology in Healthcare.Bioengineering (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abdulaziz AlMohimeedCollege of Computer and Information Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13318, Saudi Arabia.ORCID 0009-0005-9862-6398
Mohamed ShehataBioengineering Department, Speed School of Engineering, University of Louisville, Louisville, KY 40292, USA.ORCID 0000-0001-6640-6183
Nora El-RashidyMachine Learning and Information Retrieval Department, Faculty of Artificial Intelligence, Kafrelsheiksh University, Kafrelsheiksh 13518, Egypt.ORCID 0000-0001-8177-9439
Sherif MostafaFaculty of Computers and Artificial Intelligence, South Valley University, Hurghada 84511, Egypt.ORCID 0000-0002-2520-4005
Amira Samy TalaatComputers and Systems Department, Electronics Research Institute, Cairo 12622, Egypt.ORCID 0000-0002-9413-3079
Hager SalehFaculty of Computers and Artificial Intelligence, South Valley University, Hurghada 84511, Egypt.ORCID 0000-0002-7758-0811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer (CCa) is the fourth most prevalent and common cancer affecting women worldwide, with increasing incidence and mortality rates. Hence, early detection of CCa plays a crucial role in improving outcomes. Non-invasive imaging procedures with good diagnostic performance are desirable and have the potential to lessen the degree of intervention associated with the gold standard, biopsy. Recently, artificial intelligence-based diagnostic models such as Vision Transformers (ViT) have shown promising performance in image classification tasks, rivaling or surpassing traditional convolutional neural networks (CNNs). This paper studies the effect of applying a ViT to predict CCa using different image benchmark datasets. A newly developed approach (ViT-PSO-SVM) was presented for boosting the results of the ViT based on integrating the ViT with particle swarm optimization (PSO), and support vector machine (SVM). First, the proposed framework extracts features from the Vision Transformer. Then, PSO is used to reduce the complexity of extracted features and optimize feature representation. Finally, a softmax classification layer is replaced with an SVM classification model to precisely predict CCa. The models are evaluated using two benchmark cervical cell image datasets, namely SipakMed and Herlev, with different classification scenarios: two, three, and five classes. The proposed approach achieved 99.112% accuracy and 99.113% F1-score for SipakMed with two classes and achieved 97.778% accuracy and 97.805% F1-score for Herlev with two classes outperforming other Vision Transformers, CNN models, and pre-trained models. Finally, GradCAM is used as an explainable artificial intelligence (XAI) tool to visualize and understand the regions of a given image that are important for a model's prediction. The obtained experimental results demonstrate the feasibility and efficacy of the developed ViT-PSO-SVM approach and hold the promise of providing a robust, reliable, accurate, and non-invasive diagnostic tool that will lead to improved healthcare outcomes worldwide.

Indexed as

cervical cancerdiagnostic modelViT-PSO-SVM

Identifiers

PMID39061811
PMCPMC11273508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.